Leukemia

Leukemia: treatments, trials & survival

Leukemia encompasses several types of blood cancers. Discover treatment breakthroughs including CAR-T cell therapy, targeted drugs, and clinical trials.

New Cases (2024)
62,770
5-Yr Survival
66.7%
Annual Deaths
23,670
Trend
Stable
See active trials

About Leukemia

Leukemia encompasses several types of blood cancers. Discover treatment breakthroughs including CAR-T cell therapy, targeted drugs, and clinical trials.

According to the National Cancer Institute’s SEER database, an estimated 62,770 new cases of leukemia will be diagnosed in the United States in 2024, with approximately 23,670 deaths. The overall 5-year relative survival rate is 66.7%.

Source: NCI SEER Data: 1975–2022

Treatment options

Current treatment approaches for leukemia depend on the stage at diagnosis, tumor characteristics, and the patient’s overall health. The most common options include:

1
Chemotherapy
2
Targeted Therapy (TKIs for CML)
3
CAR-T Cell Therapy
4
Stem Cell Transplant
5
Immunotherapy
6
Radiation Therapy

Treatment recommendations should always be discussed with a qualified oncologist. The options listed above are based on current clinical guidelines and may vary case by case.

Stages

Staging describes the extent of cancer in the body and is crucial for planning the most appropriate treatment:

Acute Lymphocytic (ALL) Acute Myeloid (AML) Chronic Lymphocytic (CLL) Chronic Myeloid (CML)

Known risk factors

Understanding risk factors can support prevention and early detection. Known risk factors for this cancer include:

Previous chemotherapy
Radiation exposure
Genetic disorders (Down syndrome)
Benzene exposure
Smoking
Family history

Not sure where to start?

A patient navigator familiar with leukemia can help you understand your options and connect you with top US hospitals. Free & confidential.

Active clinical trials

Clinical trials offer access to cutting-edge treatments not yet widely available. The trials below are sourced in real time from ClinicalTrials.gov:

Frequently asked questions

The overall 5-year survival rate for leukemia is 66.7%. Rates vary significantly by type: CML has a survival rate above 70%, while AML is around 31%.
CAR-T (Chimeric Antigen Receptor T-cell) therapy is a revolutionary treatment where a patient's T-cells are genetically modified to recognize and attack cancer cells. It has shown remarkable results in certain types of ALL and lymphomas.
Acute leukemia progresses rapidly with immature blood cells and requires immediate treatment. Chronic leukemia develops slowly with more mature cells and may be monitored before treatment begins.
Tyrosine kinase inhibitors (TKIs) like imatinib have transformed CML from a fatal disease to a manageable chronic condition, with most patients achieving long-term remission.
You’re not alone

Looking for leukemia treatment options?

A patient navigator can help you explore treatment pathways, find clinical trials near you, and connect with specialists who see leukemia every day. Free, confidential consultation.

Send a message
Free callback

Talk to a navigator

Leave your details and we’ll call you at your preferred time.